All research papers

Conditional diffusion models for high-fidelity synthetic CT generation from CBCT in nasopharyngeal carcinoma adaptive radiotherapy: a multi-center study.

LINAC-based single-isocenter stereotactic radiotherapy for multiple brain metastases.

Intervention or Conservative Management for Symptomatic Cerebral Cavernous Malformations: A Prospective, Population-Based Cohort Study.

Long-term control after stereotactic body radiotherapy for perineal recurrence of prostate cancer after radical prostatectomy and radiotherapy: A case report and review of the literature.

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Impact of Volume and Image Strategy on Dose Prescription Accuracy in Lung Stereotactic Body Radiation Therapy.

Comparative Radiolabelling of PSMA I&T and Somatostatin Analogues with ¹⁷⁷Lu and ⁹⁰Y: The Impact of SPE Purification

Radiation dose of photon-counting CT in pediatric head examinations: an anthropomorphic phantom study

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

[Translated article] Guideline to radiopharmaceutical procedures for in vitro labeling of leukocytes.

EXPRESS: Positional Impact on Ocular Lens and Thyroid Radiation Doses During Feline Cranial CT: A TLD Study of 70 Cases.

Deep learning for CT-less attenuation correction synthesis in non-small cell lung cancer: A proof-of-concept evaluated for quantitative and physical characteristics.

Fluorodeoxyglucose PET in Radiation Oncology Planning.

Planning CT-Guided Dual-Branch Attention GAN for Longitudinal CBCT Outpainting in Adaptive Radiotherapy.

A Predictive Framework for Detecting Non-Independent Tumor Dynamics in Longitudinal MR-Guided Radiotherapy

Biologically adaptive radiation oncology in oligometastatic and oligoprogressive disease: MR- and CBCT-guided adaptation, molecular imaging, dose painting, biomarkers, and AI.

Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline.

PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) AND THE PITUITARY: SAFETY AND EFFICACY.

Advances in Somatostatin-Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives

Precise localization of phosphaturic mesenchymal tumor causing tumor-induced osteomalacia: the value of dual-tracer imaging with ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT.

A Case of FDG-Avid but FAPI-Negative Peritoneal Metastatic Gastrointestinal Stromal Tumor.

Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

Construction of a survival prediction model and analysis of influencing factors for brain metastasis in non-small cell lung cancer based on multi‑parameter clinical data.

KA-TMoE: A Deep Learning Method Using Time-Series CT Radiomics to Predict Post-Radiotherapy Rib Fractures in NSCLC Patients.

Dual‑targeted radioligand therapy with [¹⁷⁷Lu]Lu‑DOTATATE plus [¹⁷⁷Lu]Lu‑DOTA‑IBA for bone metastases from neuroendocrine neoplasms: a prospective pilot study.

Beyond geometric accuracy: Evaluation of an MRI-based autocontouring prototype for brain and prostate radiotherapy

Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer.

Optimal timing of post-therapeutic [¹³¹I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review.

Efficacy, safety, and quality of life outcomes of [¹⁷⁷Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.

A simplified feline phantom and Monte-Carlo simulation can be used to evaluate radiation exposure to veterinary staff during [²¹¹At]NaAt treatment.

Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study.

Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review.

Successful Long-Term Survival With Various Modalities of Treatments Combining Minimally Invasive Surgery for Intrahepatic and Extrahepatic Recurrence of Hepatocellular Carcinoma: A Case Report.

Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on ¹⁸F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission.

First Systematic Mapping of Non-Target [68Ga]Ga-DOTANOC Uptake Across Anatomical Sites and Etiologies.

Short-Term Efficacy and Acute Toxicity of CyberKnife-Based Stereotactic Body Radiotherapy for Primary Liver Cancer: A Retrospective Cohort Study

Interfractional Monitoring of Spacer Hydrogel Morphology in Patients With Prostate Cancer Receiving SBRT Treatment.

99mTechnetium SPECT-guided functional liver-sparing radiotherapy planning for recurrent hepatocellular carcinoma: a dosimetric comparison.

Dosimetric impact of spatial separation in combined SBRT and mediastinal radiotherapy for peripheral small cell lung cancer.

Preclinical targeted alpha therapy of B7-H3-positive tumors using [²²⁵Ac]Ac-Macropa-PEG₂-enoblituzumab via EDC/NHS-mediated conjugation.

Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatment.

Swiss survey and national diagnostic reference levels for PET/CT examinations in adults.

Clinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective.

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

Frameless Stereotactic Radiosurgery (SRS) of Brain Arteriovenous Malformation (AVM); A Systematic Review, Meta-Analysis, and a Specific Analysis on Single-Session SRS.

A simple parameter to guide plan optimization for robotic pancreas SBRT.

Minimally Invasive Surgery for Spinal Metastases: Robotics, Navigation, and the Evolution of Precision Spine Oncology.

Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells.

Parameterizable salivary gland model for small-scale Monte Carlo radiopharmaceutical therapy dosimetry: evaluation of mouse and human model.

Patient Survival and Its Relation to Tumor Absorbed Dose in [¹⁷⁷Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors.

[¹⁷⁷Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Hematologic Consequences of Radiopharmaceutical Therapy: From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms.

Real-World Outcomes of [¹⁷⁷Lu]Lu-PSMA-617 in the French Early-Access Program for Patients with Metastatic Castration-Resistant Prostate Cancer.

A review of radiotherapy linear accelerator quality control techniques.

Assessment of weight-based variations in effective dose for common PET/CT scans in a tertiary hospital.

Two cases of positive ⁶⁸Ga-PSMA-11 PET imaging in stroke.

Analysis of outcome in patients with different primary localisation of neuroendocrine tumors after PRRT. 10 years single institution experience.

Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study.

Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy.

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.